Showing results (211-220 of 332) with videos related to
Sort By:
Pageof 34
International Journal of Cancer|May 4, 1995
Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201A Van Elsas, H W Nijman, C E Van der Minne, et al.Scandinavian Journal of Immunology|November 1, 1995
Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the E7 protein of human papilloma virus 16 in H-2d miceX Zhu, M Tommasino, K Vousden, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common originT van Hall, J van Bergen, P A van Veelen, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDSS H van der Burg, M R Klein, O Pontesilli, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1982
Characterization of two subsets of human T gamma cellsR J van de Griend, I ten Berge, H J Tanke, et al.Cancer Research|February 15, 1995
Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft modelE Hooijberg, P C van den Berk, J J Sein, et al.European Journal of Immunology|August 1, 1996
Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigenA van Elsas, S H van der Burg, C E van der Minne, et al.International Journal of Cancer|November 5, 1997
Affinity, specificity and T-cell-receptor diversity of melanoma-specific CTL generated in vitro against a single tyrosinase epitopeM J Visseren, S H van der Burg, G E Hawes, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Targeting of cytotoxic T cells against leukemic B cells by bispecific antibody (aCD3 x aCD19) does not distract the T cell from its primary targetS C Klein, S H van der Burg, L H Boer, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1995
Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19L T Vlasveld, A Hekman, F A Vyth-Dreese, et al.Pageof 34